The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine ...

Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discovery Enables primary screening with high-resolution binding First order ...

COPENHAGEN, Denmark, Feb. 17, 2021 /PRNewswire/ — Vipergen ApS announced today a published study describing a powerful new drug discovery approach that enables, for the first time, screening ...

Developing targeted small molecule quantitative workflows for clinical research presents many challenges to researchers. From determining the optimum methods needed to enhance selectivity and ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

KYOTO & FUJISAWA, Japan--(BUSINESS WIRE)--xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) today announced the launch of a joint research ...